Effect of piroxicam on lipid membranes: Drug encapsulation and gastric toxicity aspects
- 1 March 2017
- journal article
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 100, 116-125
Abstract
No abstract availableKeywords
Funding Information
- European Regional Development Fund (POIG.02.01.00-12-023/08)
- European Research Council
- Research Council of Finland
- Narodowe Centrum Nauki (DEC-2012/07/B/ST5/00913)
This publication has 43 references indexed in Scilit:
- Rational design of liposomal drug delivery systems, a review: Combined experimental and computational studies of lipid membranes, liposomes and their PEGylationBiochimica et Biophysica Acta (BBA) - Biomembranes, 2016
- PEGylated Liposomes as Carriers of Hydrophobic PorphyrinsThe Journal of Physical Chemistry B, 2015
- Drug-Lipid Membrane Interaction Mechanisms Revealed Through Molecular SimulationsCurrent Physical Chemistry, 2012
- A theoretical and spectroscopic study of conformational structures of piroxicamSpectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2010
- Interaction of oxicam NSAIDs with DMPC vesicles: differential partitioning of drugsChemistry and Physics of Lipids, 2005
- Effect of anti-inflammatory drugs on splenocyte membrane fluidityAnalytical Biochemistry, 2005
- Spectroscopic studies of microenvironment dictated structural forms of piroxicam and meloxicamJournal of Luminescence, 2002
- Piroxicam Encapsulated in Liposomes: Characterization and In Vivo Evaluation of Topical Anti-inflammatory EffectDrug Development and Industrial Pharmacy, 1999
- LINCS: A linear constraint solver for molecular simulationsJournal of Computational Chemistry, 1997
- Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systemsThe Journal of Chemical Physics, 1993